Ethosomes: Carrier for Enhanced Transdermal Drug Delivery System

INTRODUCTION Skin is the largest human organ and consists of three functional layers: epidermis, dermis, and sub cutis. It has a wide variety of functions. One major task of the skin is to protect the organism from water loss and mechanical, chemical, microbial and physical influences. The protective properties are provided by the outermost layer (epidermis) of the skin. Dermal drug delivery is used for the treatment of various skin diseases. This has the advantage that high concentrations of drugs can be localized at the site of action, reducing the systemic side effects. Transdermal drug delivery system can be used as an alternative delivery of drug into the systemic circulation.1-2, Transdermal drug delivery offers many advantages as compared to traditional drug delivery systems, including oral and parenteral drug delivery system. Transdermal route is a better alternative to achieve constant plasma levels for prolonged periods of time, which additionally could be advantageous because of less frequent dosing regimens (Cal et al 2008). Advantages claimed are increased patient acceptability, avoidance of first pass metabolism, predictable and extended duration of activity, minimizing side effects and utility of short half life drugs, improving physiological and pharmacological response, avoiding the fluctuation in drug levels. The barrier function govern by stratum coneum is main problem for delivery of drugs across the skin.5-12 The stratum corneum consists of corneocytes surrounded by lipid layers, which play an essential role in the barrier properties of the stratum corneum. In order to increase the number of drugs administered via transdermal route, novel drug delivery systems have to be designed. These systems include use of physical means, such as iontophoresis, sonophoresis, micro needles, etc. and chemical means like penetration enhancers (surfactants and organic solvents) and biochemical means using liposome, noisome, transferosomes and Ethosomes also have been reported to enhance permeability of drug through the stratum corneum .The vesicles have been well known for their importance in cellular communication and particle transportation for many years. Researchers have understood the properties of vesicles structure for use in better drug delivery within their cavities, Review Article

[1]  M. Malcangio,et al.  The role of glia in the spinal cord in neuropathic and inflammatory pain. , 2015, Handbook of experimental pharmacology.

[2]  Shivaprakash,et al.  Ethosomes: A Novel Tool for Transdermal Drug Delivery , 2013 .

[3]  A. Pathak,et al.  PREPARATION AND EVALUATION OF CAPTOPRIL TRANSDERMAL PATCHES , 2011 .

[4]  S. Talegaonkar,et al.  DESIGN AND DEVELOPMENT OF O/W NANOEMULSION FOR THE TRANSDERMAL DELIVERY OF ONDANSETRON , 2011 .

[5]  G. Satyam,et al.  Ethosomes: A novel tool for drug delivery through the skin , 2010 .

[6]  T. Sivakumar,et al.  Ethosomes-A Priority in Transdermal Drug Delivery , 2010 .

[7]  Sajal K. Das,et al.  TRANSDERMAL IONTOPHORETIC DELIVERY OF ATENOLOL IN COMBINATION WITH PENETRATION ENHANCERS: OPTIMIZATION AND EVALUATION ON SOLUTION AND GELS , 2009 .

[8]  A. Misra,et al.  Ethosomes: a novel delivery system for antifungal drugs in the treatment of topical fungal diseases. , 2009, Indian journal of experimental biology.

[9]  J. Manosroi,et al.  Novel Elastic Nanovesicles for Cosmeceutical and Pharmaceutical Applications , 2009 .

[10]  K. Cal Skin disposition of menthol after its application in the presence of drug substances , 2008, Biopharmaceutics & drug disposition.

[11]  Yuefeng Rao,et al.  In Vitro Percutaneous Permeation and Skin Accumulation of Finasteride Using Vesicular Ethosomal Carriers , 2008, AAPS PharmSciTech.

[12]  D. Paolino,et al.  Innovative Drug Delivery Systems for the Administration of Natural Compounds , 2007 .

[13]  Dinesh Mishra,et al.  Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[14]  O. Abdallah,et al.  Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. , 2006, International journal of pharmaceutics.

[15]  M. L. González-Rodríguez,et al.  Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. , 2005, International journal of pharmaceutics.

[16]  B. Godin,et al.  Erythromycin ethosomal systems: physicochemical characterization and enhanced antibacterial activity. , 2005, Current drug delivery.

[17]  E. Touitou,et al.  Testosterone Ethosomes for Enhanced Transdermal Delivery , 2005, Drug delivery.

[18]  J. Lademann,et al.  Penetration profile of microspheres in follicular targeting of terminal hair follicles. , 2004, The Journal of investigative dermatology.

[19]  A. Fahr,et al.  Synergistic penetration enhancement effect of ethanol and phospholipids on the topical delivery of cyclosporin A. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[20]  G. Cevc Lipid vesicles and other colloids as drug carriers on the skin. , 2004, Advanced drug delivery reviews.

[21]  S. Jain,et al.  Ethosomes : A Novel Vesicular Carrier For Enhanced Transdermal Delivery Of An AntiHIV Agent , 2004 .

[22]  B. Godin,et al.  Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[23]  E. Touitou,et al.  Drug delivery across the skin , 2002, Expert opinion on biological therapy.

[24]  E. Touitou,et al.  Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. , 2000, Biomaterials.

[25]  B. Godin,et al.  Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[26]  G. E. El Maghraby,et al.  Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. , 2000, International journal of pharmaceutics.

[27]  J. Engblom,et al.  The skin barrier from a lipid perspective. , 2000, Acta dermato-venereologica. Supplementum.

[28]  J. Bouwstra,et al.  Electron diffraction provides new information on human stratum corneum lipid organization studied in relation to depth and temperature. , 1999, The Journal of investigative dermatology.

[29]  E. Eliav,et al.  A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis. , 1999, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[30]  Y. Chien,et al.  Novel methods of insulin delivery: an update. , 1998, Critical reviews in therapeutic drug carrier systems.

[31]  N. Weiner,et al.  Targeted delivery to the pilosebaceous unit via liposomes , 1996 .

[32]  A. Schätzlein,et al.  TRANSDERMAL DRUG CARRIERS - BASIC PROPERTIES, OPTIMIZATION AND TRANSFER EFFICIENCY IN THE CASE OF EPICUTANEOUSLY APPLIED PEPTIDES , 1995 .

[33]  R. Baker,et al.  Transdermal delivery of levonorgestrel I: Alkanols as permeation enhancers in vitro , 1988 .

[34]  R. Daynes,et al.  Skin immunology: The Achilles heel to transdermal drug delivery☆ , 1987 .

[35]  A. Freedman Handbook of Experimental Pharmacology, vol 14. , 1972 .

[36]  R. Scheuplein,et al.  Permeability of the skin. , 1971, Physiological reviews.